| Date Filed | Type | Description |
| 10/31/2022 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 10/20/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/20/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/20/2022 |
POSASR
| Form POSASR - Post-effective Amendment to an automatic shelf registration statement: |
| 10/20/2022 |
8-K
| Quarterly results |
| 10/20/2022 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 10/18/2022 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 10/07/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 09/14/2022 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
| 09/12/2022 |
SC 13G/A
| FMR LLC reports a 0% stake in CHEMOCENTRYX INC |
| 08/31/2022 |
PREM14A
| Form PREM14A - Preliminary proxy statements relating to merger or acquisition: |
| 08/09/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 08/08/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 08/08/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 08/04/2022 |
8-K
| Quarterly results |
| 07/05/2022 |
8-K
| Quarterly results |
| 06/09/2022 |
8-K
| Quarterly results |
| 06/01/2022 |
8-K
| Quarterly results |
| 05/10/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 05/05/2022 |
8-K
| Quarterly results |
| 05/03/2022 |
8-K
| Quarterly results |
| 04/05/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/05/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/01/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 03/01/2022 |
8-K
| Quarterly results |
| 02/28/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/14/2022 |
SC 13G/A
| Schall Thomas J. reports a 6.5% stake in ChemoCentryx, Inc. |
| 02/14/2022 |
SC 13G/A
| RA CAPITAL MANAGEMENT, L.P. reports a 0% stake in ChemoCentryx, Inc. |
| 02/09/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/09/2022 |
SC 13G/A
| FMR LLC reports a 15% stake in CHEMOCENTRYX INC |
| 02/02/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/12/2021 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data |
| 11/09/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
| 10/12/2021 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
|